Market Size of Occlusion Balloon Catheter Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 5.00 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Occlusion Balloon Catheter Market Analysis
The occlusion balloon catheter market is expected to witness a CAGR of 5% during the forecast period.
Due to global lockdowns and suspended trade, there was a decline in medical diagnoses and health check-ups for non-COVID-19 patients, as healthcare activities were largely focused on COVID-19. For instance, as per the article published in the National Library of Medicine in September 2021, compared to the pre-pandemic period, the pandemic caused a significant decrease in the number of referrals and procedures completed. In addition, according to the same source, during the pandemic period, there was a marked decline in referrals and procedures carried out for cardiac procedures in Canada. Such a reduction in procedures led to a decline in patient visits to healthcare centers for intracardiac electrocardiography (ICE) procedures. However, there was an increase in various cardiac diseases during the later phase of the pandemic among COVID-19 patients, which, in turn, increased the demand for interventional cardiology. This contributed to considerable growth in the market studied.
Moreover, the global and regional players in the market studied focused more on product developments during the pandemic. For instance, BioSig Technologies Inc. presented data after successfully completing a blinded trial in 2021 for its PURE EP System. In August 2022, the company extended the commercialization of the product, a computerized system designed for collecting, digitizing, amplifying, filtering, measuring, and calculating electrocardiographic and intracardiac signals. It also records and stores the signals. Hence, development activities by major players during the pandemic period fueled the growth of the market studied.
Factors such as the increasing prevalence of cardiac diseases are expected to increase the market's growth. According to the 'Cardiovascular Diseases Statistics,' published by Eurostat in August 2021, cardiovascular disorders (CVDs) are the leading cause of mortality in Europe. They span various circulatory system-related medical conditions and place a considerable burden on healthcare systems and government budgets. Additionally, as per a press release by the European Society of Cardiology in September 2021, CVD caused 36% of all fatalities in Europe. In addition, as per the same source mentioned above, people of all ages are severely affected by CVD. In Europe, CVD is responsible for about 20% of all premature deaths (before the age of 65) annually.
Furthermore, as per the article published in the National Library of Medicine in February 2022, over the past 35 years, the prevalence of obesity has more than doubled. Additionally, as per the same source mentioned above, the middle-income European Society of Cardiology member countries face a high CVD burden with a projected incidence rate around 30% higher than those of high-income countries, and the disability-adjusted life years lost to CVD are about four times higher in middle-income countries than in high-income ones.
However, the high cost of angioplasty procedures and the dearth of skilled professionals are hampering the market's growth.
Occlusion Balloon Catheter Industry Segmentation
A balloon catheter is used in order to widen a narrow opening or passage within the body during a catheterization procedure. It is a type of "soft" catheter with an inflatable "balloon" at its tip. The deflated balloon catheter is put in place and inflated to carry out the required procedure, then deflated once more to be taken out. The device consists of a balloon and a catheter. The report covers the occlusion balloon catheters that are used in cardiac and peripheral interventions.
The occlusion balloon catheter market is segmented by material (latex, silicone, and other materials), indication (peripheral vascular diseases, coronary artery disease, and other indications), end user (hospitals, ambulatory surgical centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers values in USD million for all the above-mentioned segments.
By Material | |
Latex | |
Silicone | |
Other Materials |
By Indication | |
Peripheral Vascular Diseases | |
Coronary Artery Diseases | |
Other Indications |
By End User | |
Hospitals | |
Ambulatory Surgical Centers | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Occlusion Balloon Catheter Market Size Summary
The occlusion balloon catheter market is poised for steady growth, driven by the increasing prevalence of cardiac diseases and advancements in medical technology. The market experienced a temporary setback during the pandemic due to a decline in non-COVID-19 medical procedures, but this was offset by a surge in demand for interventional cardiology as cardiac conditions rose among COVID-19 patients. Key industry players focused on product development and innovation during this period, contributing to market expansion. The rising incidence of cardiovascular diseases, particularly in Europe, and the growing geriatric population are expected to further propel market growth. However, challenges such as the high cost of angioplasty procedures and a shortage of skilled professionals may hinder progress.
North America is anticipated to maintain a significant market share, supported by a large patient pool, rapid technological advancements, and increased healthcare spending. The region's market growth is further bolstered by the prevalence of vascular diseases and congenital heart defects. The market is moderately fragmented, with major players like Boston Scientific Corp., Cook Group Incorporated, and Stryker Corporation actively engaging in new product developments and geographical expansion. Recent product launches, such as Abbott's Portico with FlexNav transcatheter aortic valve replacement system, highlight the ongoing innovation in the sector. These factors collectively suggest a positive outlook for the occlusion balloon catheter market over the forecast period.
Occlusion Balloon Catheter Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Geriatric Population and Rising Prevalence of Cardiac Diseases
-
1.2.2 Increasing Disposable Income and Healthcare Spending
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Catheterization Procedures
-
1.3.2 The Dearth of Skilled Professionals and Risk of Infection
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Material
-
2.1.1 Latex
-
2.1.2 Silicone
-
2.1.3 Other Materials
-
-
2.2 By Indication
-
2.2.1 Peripheral Vascular Diseases
-
2.2.2 Coronary Artery Diseases
-
2.2.3 Other Indications
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
2.3.3 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Occlusion Balloon Catheter Market Size FAQs
What is the current Occlusion Balloon Catheter Market size?
The Occlusion Balloon Catheter Market is projected to register a CAGR of 5% during the forecast period (2024-2029)
Who are the key players in Occlusion Balloon Catheter Market?
Boston Scientific Corp., Cook Group Incorporated, Stryker Corporation, W. L. Gore & Associates and Oscor, Inc. are the major companies operating in the Occlusion Balloon Catheter Market.